Emergent says it has disposed of spoilt COVID-19 vaccine batch
Tweet
Share
E-mail
FILE PHOTO: A nurse draws from a vial of Johnson & Johnson coronavirus disease (COVID-19) vaccine, in Los Angeles, California, U.S., March 25, 2021. REUTERS/Lucy Nicholson/File Photo
(Reuters) - Johnson & Johnson's manufacturing partner Emergent Biosolutions said on Thursday that it had discarded the single batch of COVID-19 drug substance that did not meet specifications.
J&J on Wednesday said it had found a problem with a batch of the drug substance for its COVID-19 vaccine being produced at Emergent's site in Baltimore, Maryland.
The New York Times reported on Wednesday that about 15 million doses were ruined, without citing a source.
"Discarding a batch of bulk drug substance, while disappointing, does occasionally happen during vaccine manufacturing, which is a complex and multi-step biological process," Emergent said.
(Reporting by Dania Nadeem in Bengaluru; Editing by Anil D'Silva)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Weak GDP, strong prices, highlight Fed dilemma
- Hamas insists Gaza war end for any hostage deal, says won't be swayed by U.S. pressure
- Burkina Faso army executed over 220 villagers in February, HRW says
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
